Insights

Innovative Diagnostic Platform Nanosphere's Verigene System offers rapid and targeted molecular diagnostics for infectious diseases, positioning it as a key provider of advanced healthcare solutions that can address hospitals and laboratories seeking to improve diagnostic speed and accuracy.

Growth and Revenue Potential With a revenue range of 25 to 50 million dollars and ongoing scientific innovation reflected in over 175 patents, Nanosphere presents a promising opportunity for partners aiming to enhance infectious disease testing with cutting-edge technology.

Focused Disease Coverage Targeting infections in bloodstream, respiratory, and gastrointestinal tracts, Nanosphere's offerings align well with healthcare providers striving to reduce infectious disease burden, creating sales opportunities in clinical microbiology and hospital labs.

Strategic Industry Position As a Luminex company with established ties in biotech and molecular diagnostics, Nanosphere operates within a competitive landscape alongside major players like Qiagen and Bio-Rad, making it a strategic partner for expanding diagnostic portfolios and technological integration.

Funding and Market Activities Despite recent share consolidation in its related health sciences segment, Nanosphere’s strong financial foundation and ongoing commitment to innovation make it a compelling candidate for collaborations, licensing, and expanding sales channels in the molecular diagnostics market.

Nanosphere Tech Stack

Nanosphere's Email Address Formats

Nanosphere uses at least 1 format(s):
Nanosphere Email FormatsExamplePercentage
FLast@nanosphere.usJDoe@nanosphere.us
48%
FirstLast@nanosphere.usJohnDoe@nanosphere.us
2%
FLast@nanosphere.usJDoe@nanosphere.us
48%
FirstLast@nanosphere.usJohnDoe@nanosphere.us
2%

Frequently Asked Questions

Where is Nanosphere's headquarters located?

Minus sign iconPlus sign icon
Nanosphere's main headquarters is located at 4088 Commercial Ave., Northbrook, IL 60062, US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Nanosphere's phone number?

Minus sign iconPlus sign icon
You can contact Nanosphere's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nanosphere's stock symbol?

Minus sign iconPlus sign icon
Nanosphere is a publicly traded company; the company's stock symbol is NSHSF.

What is Nanosphere's official website and social media links?

Minus sign iconPlus sign icon
Nanosphere's official website is nanosphere.us and has social profiles on LinkedInCrunchbase.

How much revenue does Nanosphere generate?

Minus sign iconPlus sign icon
As of October 2025, Nanosphere's annual revenue is estimated to be $21M.

What is Nanosphere's SIC code NAICS code?

Minus sign iconPlus sign icon
Nanosphere's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nanosphere have currently?

Minus sign iconPlus sign icon
As of October 2025, Nanosphere has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer And Chief Scientific Officer: J. F.Vice President Platform Development: D. M.President: R. M.. Explore Nanosphere's employee directory with LeadIQ.

What industry does Nanosphere belong to?

Minus sign iconPlus sign icon
Nanosphere operates in the Biotechnology Research industry.

What is Nanosphere's email format?

Minus sign iconPlus sign icon
Nanosphere's email format typically follows the pattern of FLast@nanosphere.us. Find more Nanosphere email formats with LeadIQ.

How much funding has Nanosphere raised to date?

Minus sign iconPlus sign icon
As of October 2025, Nanosphere has raised $4.1M in funding. The last funding round occurred on May 29, 2015 for $4.1M.

Nanosphere

Biotechnology ResearchUnited States51-200 Employees

Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.

Nanosphere’s platform, the Verigene® System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases. 

Headquartered in Northbrook, Illinois, Nanosphere was founded in 1999 based upon technology developed at Northwestern University by Dr. Robert Letsinger and Dr. Chad Mirkin. In 2007, Nanosphere went public (NASDAQ: NSPH), and has remained committed to continued scientific discovery and innovation with more than 175 patents to its name. 

Currently, our test menu targets infections of the bloodstream, respiratory tract and gastrointestinal tract.

Nanosphere is now a Luminex company.

Section iconCompany Overview

Headquarters
4088 Commercial Ave., Northbrook, IL 60062, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NSHSF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $4.1M

    Nanosphere has raised a total of $4.1M of funding over 6 rounds. Their latest funding round was raised on May 29, 2015 in the amount of $4.1M.

  • $25M$50M

    Nanosphere's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $4.1M

    Nanosphere has raised a total of $4.1M of funding over 6 rounds. Their latest funding round was raised on May 29, 2015 in the amount of $4.1M.

  • $25M$50M

    Nanosphere's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.